Search

Your search keyword '"Martino, Massimo"' showing total 13 results
Start Over Author "Martino, Massimo" Journal biology of blood and marrow transplantation
13 results on '"Martino, Massimo"'

1. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Author

Bazarbachi, Ali, Labopin, Myriam, Angelucci, Emanuele, Gülbas, Zafer, Ozdogu, Hakan, Arat, Mutlu, de Rosa, Luca, Pastano, Rocco, Pioltelli, Pietro, Montserrat, Rovira, Martino, Massimo, Ciceri, Fabio, Koç, Yener, Socié, Gerard, Blaise, Didier, Herrera, Concepcion, Chalandon, Yves, Bernasconi, Paolo, Marotta, Giuseppe, Castagna, Luca, McDonald, Andrew, Visani, Guiseppe, Carluccio, Paola, Vitek, Antonin, Simand, Célestine, Afanasyev, Boris, Rösler, Wolf, Diez-Martin, J.L., Nagler, Arnon, Brissot, Eolia, Giebel, Sebastian, and Mohty, Mohamad

Published
2020
Full Text
View/download PDF

2. Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34+ Cell and Platelet Counts

Author

Martino, Massimo, Gori, Mercedes, Moscato, Tiziana, Naso, Virginia, Ferreri, Anna, Provenzano, Fabio, Loteta, Barbara, Sanguedolce, Maria Cristina, Console, Giuseppe, Dattola, Antonia, Pucci, Giulia, Gentile, Massimo, Morabito, Antonella, Recchia, Anna Grazia, Tripepi, Giovanni, and Pitino, Annalisa

Published
2019
Full Text
View/download PDF

3. Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony–Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study

Author

Martino, Massimo, Gori, Mercedes, Pitino, Annalisa, Gentile, Massimo, Dattola, Antonia, Pontari, Antonella, Vigna, Ernesto, Moscato, Tiziana, Recchia, Anna Grazia, Barilla', Santina, Tripepi, Giovanni, and Morabito, Fortunato

Published
2017
Full Text
View/download PDF

4. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry

Author

Martino, Massimo, Lanza, Francesco, Pavesi, Lorenzo, Öztürk, Mustafa, Blaise, Didier, Leno Núñez, Rubén, Schouten, Harry C., Bosi, Alberto, De Giorgi, Ugo, Generali, Daniele, Rosti, Giovanni, Necchi, Andrea, Ravelli, Andrea, Bengala, Carmelo, Badoglio, Manuela, Pedrazzoli, Paolo, and Bregni, Marco

Published
2016
Full Text
View/download PDF

7. Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study

Author

Martino, Massimo, Montanari, Mauro, Ferrara, Felicetto, Ciceri, Fabio, Scortechini, Ilaria, Palmieri, Salvatore, Marktel, Sarah, Cimminiello, Michele, Messina, Giuseppe, Irrera, Giuseppe, Offidani, Massimo, Console, Giuseppe, Castagna, Luca, Milone, Giuseppe, Bruno, Benedetto, Tripepi, Giovanni, Lemoli, Roberto Massimo, and Olivieri, Attilio

Published
2014
Full Text
View/download PDF

8. Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry

Author

Pedrazzoli, Paolo, Martinelli, Giovanni, Gianni, Alessandro Massimo, Da Prada, Gian Antonio, Ballestrero, Alberto, Rosti, Giovanni, Frassineti, Giovanni Luca, Aieta, Michele, Secondino, Simona, Cinieri, Saverio, Fedele, Roberta, Bengala, Carmelo, Bregni, Marco, Grasso, Donatella, De Giorgi, Ugo, Lanza, Francesco, Castagna, Luca, Bruno, Barbara, and Martino, Massimo

Published
2014
Full Text
View/download PDF

9. A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model

Author

Martino, Massimo, Ciavarella, Sabino, De Summa, Simona, Russo, Letteria, Meliambro, Nicola, Imbalzano, Lucrezia, Gallo, Giuseppe Alberto, Moscato, Tiziana, Messina, Giuseppe, Ferreri, Anna, Cuzzola, Maria, Irrera, Giuseppe, Naso, Virginia, Cimminiello, Michele, Console, Giuseppe, Loseto, Giacomo, Tommasi, Stefania, and Guarini, Attilio

Published
2018
Full Text
View/download PDF

10. Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML- No Association with Graft-Versus-Host Disease (GVHD): A Study on Behalf of the Acute Leukemia Working Party of EBMT.

Author

Shimoni, Avichai, primary, Labopin, Myriam, additional, Angelucci, Emanuele, additional, Blaise, Didier, additional, Ciceri, Fabio, additional, Koc, Yener, additional, Gulbas, Zafer, additional, Diez-Martin, José Luis, additional, Bruno, Benedetto, additional, Castagna, Luca, additional, Martino, Massimo, additional, Rovira, Montserrat, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2019
Full Text
View/download PDF

11. Basal CD34 + Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony–Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study

Author

Martino, Massimo, primary, Gori, Mercedes, additional, Pitino, Annalisa, additional, Gentile, Massimo, additional, Dattola, Antonia, additional, Pontari, Antonella, additional, Vigna, Ernesto, additional, Moscato, Tiziana, additional, Recchia, Anna Grazia, additional, Barilla', Santina, additional, Tripepi, Giovanni, additional, and Morabito, Fortunato, additional

Published
2017
Full Text
View/download PDF

13. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry

Author

Andrea Ravelli, Alberto Bosi, Paolo Pedrazzoli, Manuela Badoglio, Carmelo Bengala, Andrea Necchi, Marco Bregni, Ruben Leno Nunez, Mustafa Ozturk, Francesco Lanza, Didier Blaise, Lorenzo Pavesi, Giovanni Rosti, Daniele Generali, Massimo Martino, Ugo De Giorgi, Hendricus Schouten, Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Martino, Massimo, Lanza, Francesco, Pavesi, Lorenzo, Öztürk, Mustafa, Blaise, Didier, Leno Núñez, Rubén, Schouten, Harry C., Bosi, Alberto, De Giorgi, Ugo, Generali, Daniele, Rosti, Giovanni, Necchi, Andrea, Ravelli, Andrea, Bengala, Carmelo, Badoglio, Manuela, Pedrazzoli, Paolo, Bregni, Marco, Martino, M, Lanza, F, Pavesi, L, Ozturk, M, Blaise, D, Nunez, Rl, Schouten, Hc, Bosi, A, De Giorgi, U, Generali, D, Rosti, G, Necchi, A, Ravelli, A, Bengala, C, Badoglio, M, Pedrazzoli, P, and Bregni, M

Subjects
Adult, Oncology, medicine.medical_specialty, High-risk breast cancer, medicine.medical_treatment, Population, Breast Neoplasms, Hematopoietic stem cell transplantation, Disease-Free Survival, NO, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, High-dose chemotherapy, medicine, Chemotherapy, Humans, Registries, Autografts, education, Survival rate, Adjuvant, Aged, Transplantation, education.field_of_study, Hematology, business.industry, Mortality rate, Hematopoietic Stem Cell Transplantation, Middle Aged, medicine.disease, Autologous hematopoietic stem cell transplantation, Surgery, Europe, Survival Rate, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, business, 030215 immunology
Abstract

The aim of this retrospective study was to assess toxicity and efficacy of adjuvant high-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (AHSCT) in 583 high-risk breast cancer (BC) patients (>3 positive nodes) who were transplanted between 1995 and 2005 in Europe. All patients received surgery before transplant, and 55 patients (9.5%) received neoadjuvant treatment before surgery. Median age was 47.1 years, 57.3% of patients were premenopausal at treatment, 56.5% had endocrine-responsive tumors, 19.5% had a human epidermal growth factor receptor 2 (HER2)-negative tumor, and 72.4% had >= 10 positive lymph nodes at surgery. Seventy-nine percent received a single HDC procedure. Overall transplant-related mortality was 1.9%, at .9% between 2001 and 2005, whereas secondary tumor-related mortality was .9%. With a median follow-up of 120 months, overall survival and disease-free survival rates at 5 and 10 years in the whole population were 75% and 64% and 58% and 44%, respectively. Subgroup analysis demonstrated that rates of overall survival were significantly better in patients with endocrine-responsive tumors

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results